Advanced SearchNewsfeedFollowed Companies

Inovio's Competitors, Revenue, Number of Employees, Funding and Acquisitions

Inovio is a pharmaceutical company that researches, develops and commercializes synthetic vaccines and immune therapies ... Read more

Based on data from Inovio's latest SEC filings

Annual Revenue

Based on data from Inovio's latest SEC filings

Employees

J. Joseph Kim's photo - President & CEO of Inovio

President & CEO

J. Joseph Kim

CEO Approval Rating

65/100

OVERVIEW

Founded:

1979

Headquarters:

Plymouth MeetingPennsylvania

Status:

PublicNASDAQINO

Industry Sector:

Biotechnology

SIC Code:

8090NAICS listing »

8000NAICS listing »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is bluebird bio a competitor of Inovio?

I don't know

Trending News for Inovio and Inovio's Competitors

February 20, 2020

MarketScreener

Agenus Announces Positive Interim Data from Balstilimab and Zalifrelimab Clinical Trials in Second-Line Cervical Cancer

(marketscreener.com) LEXINGTON, Mass., Feb. 20, 2020 /PRNewswire/ -- Agenus Inc. , an immuno-oncology... See more »

February 20, 2020

Benzinga

Zynerba Pharmaceuticals Announces Presentations at the American Society for Experimental Neurotherapeutics (ASENT) 2020 Annual Meeting

DEVON, Pa., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader... See more »

February 19, 2020

Benzinga

Aduro Biotech to Present at the 9th Annual SVB Leerink Global Healthcare Conference

BERKELEY, Calif., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced... See more »

Competitive Analysis

TOP COMPETITORS OR ALTERNATIVES

Dynavax is seen as one of Inovio's biggest rivals. Dynavax is headquartered in Emeryville, California, and was founded in 1996. Like Inovio, Dynavax also works within the Biotechnology sector. Dynavax generates 473% the revenue of Inovio.

Advaxis is seen as one of Inovio's top competitors. Advaxis was founded in 2002, and its headquarters is in Princeton, New Jersey. Advaxis operates in the Biotechnology industry. Advaxis has 246 fewer employees than Inovio.

Aduro is one of Inovio's top rivals. Aduro is a Public company that was founded in Berkeley, California in 2000. Aduro operates in the Biotechnology industry. Aduro has 129 fewer employees vs. Inovio.

RANK

COMPANY

LEADERSHIP

CEO SCORE

EMPLOYEES

TOTAL FUNDING

REVENUE

J. Joseph Kim

President & CEO

- -
281
$290.1M
$6.3M
1

Ryan Spencer

CEO

83/100
249
$450.1M
$30M
2

Kenneth A. Berlin

President & CEO

81/100
35
$53.6M
$20.9M
3

Stephen T. Isaacs

Chairman & CEO

89/100
152
$272.4M
$16.4M
4

Nick Leschly

President & CEO

80/100
764
$275.9M
$53.9M
5

Lothar Germeroth

Managing Director

80/100
663
$1.5B
$106M
6

Christi L. Shaw

CEO

81/100
447
$225.2M
$32.1M
7

Carlos Paya

President & CEO

91/100
50
$160.5M
$2.2M
8

Garo H. Armen

Chairman & CEO

90/100
294
$284.2M
$122M
9

Thomas J. Schall

Chairman & CEO

87/100
76
$289.5M
$35.4M
10

Armando Anido

Chairman & CEO

79/100
25
$55M
$ < 1M
The top 10 competitors in Inovio's competitive set are Dynavax, Advaxis, Aduro, bluebird bio, Juno, Kite, Immune Design, Agenus, ChemoCentryx and Zynerba. Together they have raised over 3.6B between their estimated 3.3K employees. Inovio has 281 employees and is ranked 5th among it's top 10 competitors. The top 10 competitors average 276.

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$6.3M

Inovio's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 38.7M. Over the last four quarters, Inovio's revenue has decreased by 65.4%. Specifically, in Q3 2019's revenue was $ < 1M; in Q2 2019, it was $ < 1M; in Q1 2019, it was $2.8M; in Q4 2018, Inovio's revenue was $2.5M.

Acquisitions

No recent acquisitions found related to Inovio

Inovio Funding History

Since Inovio was founded in 1979, it has participated in 13 rounds of funding. In total Inovio has raised $290.1M. Inovio's last funding round was on Jan 2020 for a total of $9.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Grant
Jan 2020
$9M

Coalition for Epidemic Preparedness Innovations

Debt
Dec 2019
$4M
-
Grant
Sep 2019
--
Private Placement
Jul 2019
$15.2M
Unattributed
Apr 2018
$56M

Total Funding: $290.1M

Since Inovio was founded in 1979, it has participated in 13 rounds of funding. In total Inovio has raised $290.1M. Inovio's last funding round was on Jan 2020 for a total of $9.0M

Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Geneos is a pharmaceutical company that researches and develops immunotherapeutics for the treatment of cancer.
$10.5M
Feb 20, 2019
Series A
-

Inovio News

February 7, 2020Seeking Alpha

Inovio -4.1% after amendment to Stifel sales deal

See more »
February 4, 2020news.elearninginside

TOP HAT ANNOUNCES $55 MILLION SERIES D TO SCALE OPERATIONS

Top Hat, the Toronto-based OER platform, said it had raised a Series D funding round worth $55 millio... See more »
February 3, 2020Seeking Alpha

Inovio's INO-3106 shows encouraging action in pilot study

See more »
February 3, 2020Homeland Preparedness News

Inovio Pharmaceuticals announces novel coronavirus vaccine collaboration with Beijing Advaccine

A collaboration between Inovio Pharmaceuticals, Inc. and Beijing Advaccine Biotechnology Co. announce... See more »
February 3, 2020FIRSTWORD PHARMA

Inovio Pharmaceuticals Drops 14% After Registering Offering of 2 Million Shares

Inovio Pharmaceuticals' shares fell by 14% intraday after it said late last week that it planned to s... See more »
February 1, 2020Pharmabiz

Inovio, Beijing Advaccine collaborate to develop INO─4800 vaccine against new coronavirus in China

Inovio Pharmaceuticals Inc, a biotechnology company, announced that it is collaborating with Beijing ... See more »
January 30, 2020Seeking Alpha

Prepare For More Dilution Of Inovio Pharmaceuticals Yet Again

See more »

Inovio Press Releases

April 2, 2019PR Newswire Asia

Inovio Presents Cancer Killing Data of Its Transformative DNA-Encoded Bi-specific T Cell Engagers (dBiTEs) at AACR

Data demonstrates tumor-clearing ability of Inovio's dBiTE technology in preclinical cancer modelPLYM... See more »
January 7, 2019PR Newswire Asia

Inovio's DNA-Encoded Monoclonal Antibody (dMAb(TM)) Platform Leaps Forward with First-in-Human Trial

First Human dMAb Study Will Target Zika InfectionPLYMOUTH MEETING, Pennsylvania, Jan. 7, 2019 /PRNews... See more »
November 15, 2018GlobeNewswire

Inovio Prepares for Growth & Commercialization With Leadership Appointments

PLYMOUTH MEETING, Pa., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) m... See more »
May 31, 2018StreetInsider

Inovio CEO to Speak on Viral Epidemic Preparedness Panel at BIO International Convention

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that Dr. J. Joseph Kim, President and CEO,... See more »
May 9, 2018StreetInsider

Inovio Pharmaceuticals Reports 2018 First Quarter Financial Results

PLYMOUTH MEETING, Pa., May 09, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO), a... See more »
April 19, 2018Newswise

Wistar Team Receives Prestigious Award from National Clinical Research Forum for DNA-based Zika Research

Wistar and partners at the Perelman School of Medicine, University of Pennsylvania; Inovio Pharmaceut... See more »
March 14, 2018GlobeNewswire

Inovio's DNA Immunotherapy Demonstrates Immune Response Results Key in Treating Chronic Hepatitis B Infection

INO-1800 shows ability to activate and expand CD8+ killer T cells... See more »

Inovio Videos

January 26, 2017Inovio Youtube Channel

"Welcome to Inovio 2017" on YOUTUBE

See more »
September 2, 2015Inovio Youtube Channel

"Cancer Cell Destruction" on YOUTUBE

See more »
June 11, 2015Inovio Youtube Channel

"VGXI Congressional Visit" on YOUTUBE

See more »
May 21, 2014Inovio Youtube Channel

"Inovio Research Center Building Dedication" on YOUTUBE

See more »
February 25, 2014Inovio Youtube Channel

"Inovio scientific advisors & board member discuss DNA immunotherapy potential" on YOUTUBE

See more »

Social Statistics

Headquarters

660 West Germantown Pike Suite 110

Plymouth Meeting, Pennsylvania19462

1-267-440-4200

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Inovio is a pharmaceutical company that researches, develops and commercializes synthetic vaccines and immune therapies for the treatment of cancer. Inovio was founded in 1979. Inovio's headquarters is located in Plymouth Meeting, Pennsylvania, USA 19...

CEO

Inovio's President & CEO, J. Joseph Kim, currently has an approval rating of 65%. Inovio's primary competitors are Dynavax, Advaxis & Aduro.

Website

inovio.com

Frequently Asked Questions about Inovio

  1. When was Inovio founded?

    Inovio was founded in 1979

  2. Who is Inovio's CEO?

    Inovio's CEO is J. Joseph Kim

  3. How much revenue does Inovio generate?

    Inovio generates $6.3M in revenue

  4. How much funding does Inovio have?

    Inovio has historically raised $290.1M in funding

  5. Where is Inovio's headquarters?

    Inovio's headquarters is in Plymouth Meeting Pennsylvania, USA

  1. How many employees does Inovio have?

    Inovio has 281 employees

  2. What sector does Inovio operate in?

    Inovio is in Biotechnology

  3. Who are Inovio's competitors?

    Inovio's top competitors are Dynavax, Advaxis, Aduro

  4. Who has Inovio invested in?

    Inovio's has invested in companies such as Geneos Therapeutics
Stay up-to-date with the latest news on Inovio